1. Biomarkers in Coronary Artery Bypass Surgery: Ready for Prime Time and Outcome Prediction?
   Alessandro Parolari et al, 2016, Frontiers in Cardiovascular Medicine CrossRef
2. Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients
   Sarah Farid fahmy et al, 2023, BMC Pharmacology and Toxicology CrossRef
3. Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19
   Tomas Rajtik et al, 2021, International Journal of Molecular Sciences CrossRef
4. COVID-19: The Cause of the Manifested Cardiovascular Complications During the Pandemic
   Audditiya Bandopadhyay et al, 2021, Frontiers in Cardiovascular Medicine CrossRef
5. Renin-angiotensin system blockers in cardiac surgery
   Antonio Mangieri, 2015, Journal of Critical Care CrossRef
6. Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19
   Taravat Talebi et al, 2023, Genetics Research CrossRef
7. Renoprotective effects of berberine as adjuvant therapy for hypertensive patients with type 2 diabetes mellitus: Evaluation via biochemical markers and color Doppler ultrasonography
   PEIFENG DAI et al, 2015, Experimental and Therapeutic Medicine CrossRef
8. Serum angiotensin-converting enzyme 2 is an independent risk factor for in-hospital mortality following open surgical repair of ruptured abdominal aortic aneurysm
   Wanpin Nie et al, 2016, Experimental and Therapeutic Medicine CrossRef
9. Genetic Association of ACE2 rs2285666 Polymorphism With COVID-19 Spatial Distribution in India
   Anshika Srivastava et al, 2020, Frontiers in Genetics CrossRef
10. The role of SARS‐CoV‐2 target ACE2 in cardiovascular diseases
    Hanzhao Zhu et al, 2021, Journal of Cellular and Molecular Medicine CrossRef